Changes in bone mineral content during long-term CAPD. Indication of a sex-dependent bone mineral loss

Change in bone mineral content (BMC) was evaluated in a longitudinaltrial comprising 12 women and 11 men with chronic renal diseasetreated with CAPD and 1-alpha-OH-D3 for 2 years. The patientsserved as their own controls. No patients were treated withsteroids. Median age was 54 and 60 years for women and men respectively.No significant difference in 1-alpha-OH-D3 dosage or serum 1,25(OH)₂D3was found between the genders in the study period. Bone mineral content at the distal radius deteriorated significantlyin the females with a median decrease of 12% over 2 years, i.e.approximately 6% per year (P<0.001 and 95% confidence limits8–20%). No significant change was noted in the males.There was no correlation between age and BMC change. Serum total alkaline phosphatase decreased nonsignificantlyin both sexes. Total serum calcium increased significantly (P<0.05)and serum phosphate decreased significantly (P<0.05) in thewomen. Serum albumin and body weight decreased significantlyin the males (P<0.01 and P<0.05) while no change was seenin the females. The demonstrated decrease in BMC in the female patients of approximately6% per year exceeds the commonly observed loss of 1–2%per year in healthy women when measured with the same technique.Tentatively, the severe mineral loss in the women could indicatea sex-hormone-related disturbance in bone metabolism of uraemicfemales.